UnknownNot Applicable

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage

China1,600 participantsStarted 2022-09-01

Plain-language summary

This multicenter observational study will explore the risk factors of early neurological deterioration(END) in patients with primary and to investigate the association between END and outcome.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed diagnosis of primary intracerebral hemorrhage Exclusion Criteria: * Patients with secondary * Undergo surgical evacuation of hematoma； * Presenting contraindications or refusal to MRI * Is pregnant * Patients refuse to be followed up for any reasons.

What they're measuring

Early neurological deterioration (END)

Timeframe: 48 hours after admission

Trial details

NCT IDNCT05502874

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-01

Contact for this trial

Feng Gao, MD,PhD

13588451471 2202012@zju.edu.cn

View on ClinicalTrials.gov More Intracerebral Hemorrhage trials